The first Adaptive Biotechnologies trade was made in Q1 2021.
Since then Jim Simons bought shares two more times and sold shares on seven occasions. The investor completely sold their stake between Q3 2022 and Q4 2023.
Avg closing price
Price range
Sold -51.2 Thousand shares
Q4 2023
Avg closing price
$4.56
Price range
$3.46
-
$5.33
Sold 84.9% shares (-287 Thousand shares)
Q3 2023
Avg closing price
$6.61
Price range
$5.07
-
$8.44
Sold 14.1% shares (-55.5 Thousand shares)
Q2 2023
Avg closing price
$7.44
Price range
$6.19
-
$8.78
Sold 5.2% shares (-21.8 Thousand shares)
Q1 2023
Avg closing price
$8.82
Price range
$7.80
-
$10.11
Sold 9.2% shares (-42 Thousand shares)
Q4 2022
Avg closing price
$7.78
Price range
$6.26
-
$9.34
Sold 5.9% shares (-28.7 Thousand shares)
Q3 2022
Avg closing price
$9.42
Price range
$6.50
-
$12.67
Increased shares by 6.8% (+30.9 Thousand shares)
Q2 2022